On June 16th 2021, Olivier Laureau, President of Servier, was confirmed as Second Vice President of the European Federation of Pharmaceutical Industries and Associations (EFPIA) during its General Assembly.
As Second Vice President, Olivier Laureau will continue to defend the pharmaceutical sector, bringing in Servier’s values as well as defending the interests of the EFPIA European Mid-Size Pharmaceutical Companies.
He will be working together with the President (Hubertus Von Baumbach from Boehringer Ingelheim) and the first Vice-President (Lars Fruergaard Jørgensen from Novo Nordisk) leading the work of the federation for a two-year mandate.
“Recent events have demonstrated the key role medical innovation plays in keeping our society safe and healthy” said Olivier Laureau. “Our ambition is for Europe to be a world leader in life science. Realising that goal means EFPIA and its membership working with the EU and Member States to build a world-class regulatory system, a strong and predictable IP framework and a next generation life sciences eco-system that delivers for patients across Europe and around the world.”
Servier is a member of EFPIA since 1997.